T. Rowe Price Investment Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
+977,685
| New | +$11.3M | 0.01% | 549 |
|
|
2024
Q4 | – | Sell |
-2,161,775
| Closed | -$48.8M | – | 674 |
|
|
2024
Q3 | $48.8M | Sell |
2,161,775
-1,204
| -0.1% | -$27.2K | 0.03% | 409 |
|
|
2024
Q2 | $42.1M | Sell |
2,162,979
-41,451
| -2% | -$806K | 0.03% | 411 |
|
|
2024
Q1 | $82.7M | Buy |
2,204,430
+1,063,386
| +93% | +$39.9M | 0.05% | 316 |
|
|
2023
Q4 | $63.9M | Buy |
1,141,044
+144,379
| +14% | +$8.08M | 0.04% | 353 |
|
|
2023
Q3 | $41.1M | Hold |
996,665
| – | – | 0.03% | 392 |
|
|
2023
Q2 | $55.7M | Sell |
996,665
-29,296
| -3% | -$1.64M | 0.04% | 363 |
|
|
2023
Q1 | $57.2M | Buy |
+1,025,961
| New | +$57.2M | 0.04% | 347 |
|